# EDGAR Filing Document

**Accession Number:** 0001019034
**File Stem:** 0001437749-25-027950
**Filing Date:** 2025-8
**Character Count:** 25630
**Document Hash:** ab3ffd1e787fa0d617efe81cdcbc3779
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001437749-25-027950.hdr.sgml**: 20250828

**ACCESSION NUMBER**: 0001437749-25-027950

**CONFORMED SUBMISSION TYPE**: S-8

**PUBLIC DOCUMENT COUNT**: 18

**REFERENCES 429**: 333-257754

**FILED AS OF DATE**: 20250828

**DATE AS OF CHANGE**: 20250828

**EFFECTIVENESS DATE**: 20250828

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BIO KEY INTERNATIONAL INC
- **CENTRAL INDEX KEY:** 0001019034
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-PREPACKAGED SOFTWARE [7372]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 411761861
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** S-8
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-289919
- **FILM NUMBER:** 251274011

**BUSINESS ADDRESS:**
- **STREET 1:** 101 CRAWFORDS CORNER RD
- **STREET 2:** SUITE 4116
- **CITY:** HOLMDEL
- **STATE:** NJ
- **ZIP:** 07733
- **BUSINESS PHONE:** 7323591100

**MAIL ADDRESS:**
- **STREET 1:** 101 CRAWFORDS CORNER RD
- **STREET 2:** SUITE 4116
- **CITY:** HOLMDEL
- **STATE:** NJ
- **ZIP:** 07733

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** SAC TECHNOLOGIES INC
- **DATE OF NAME CHANGE:** 19961115

**As filed with the Securities and Exchange Commission on August 28, 2025**

**Registration No. 333-_______**

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

------

**FORM S-8**

**REGISTRATION STATEMENT** 

***UNDER THE SECURITIES ACT OF 1933***

------

**BIO-KEY INTERNATIONAL, INC.**

(Exact name of registrant as specified in its charter)

---

| | |
|:---|:---|
| **Delaware**<br> (State or other jurisdiction of incorporation or organization) | **41-1741861**<br> (I.R.S. Employer Identification No.) |
| **101 Crawfords Corner Road**<br> **Suite 4116**<br> **Holmdel, NJ**<br> (Address of Principal Executive Offices) | **07733**<br> (Zip Code) |

---

------

**BIO-key International, Inc.** 

**2021 Employee Stock Purchase Plan, as Amended**

(Full title of the plan)

**Michael W. DePasquale** 

**Chief Executive Officer** 

**BIO-key International, Inc.** 

**101 Crawfords Corner Road**

**Suite 4116**

**Holmdel, NJ 07733**

(Name and address of agent for service)

**(732) 359-1100**

(Telephone number, including area code, of agent for service)

**Copies requested to:**

**Vincent A. Vietti, Esquire**

**Fox Rothschild LLP**

**212 Carnegie Center**

**Suite 400**

**Princeton, NJ 08540**

**(609) 896-3600**

------

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ Accelerated filer ☐ <br> Non-accelerated filer ☒ Smaller reporting company ☒ <br> Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

------

**EXPLANATORY NOTE** 

BIO-key International, Inc. (the "Company" or the "Registrant") has filed this Registration Statement on Form S-8 (the "Registration Statement") with the Securities and Exchange Commission (the "SEC") pursuant to General Instruction E to Form S-8 under the Securities Act of 1933, as amended, to register an additional 700,000 shares of the Company's common stock, par value $0.0001 per share (the "Common Stock"), issuable under the BIO-key International, Inc. 2021 Employee Stock Purchase Plan, as amended (the "ESPP"). This share increase was approved by the Company's Board of Directors, upon recommendation of the Compensation Committee, on June 18, 2025, and was approved and adopted by the Company's stockholders on August 8, 2025. The Company previously filed with the SEC a Registration Statement on Form S-8 (Reg. No. 333-257754) to register the initial 43,834 shares of Common Stock available for issuance under the ESPP, which prior Registration Statement, with the exception of Items 3 and 8 of Part II of such prior Registration Statement, is hereby incorporated by reference.

All figures have been adjusted to reflect the 18-for-1 stock split effected on December 20, 2023.

------

**PART II**

**INFORMATION REQUIRED IN THE REGISTRATION STATEMENT**

**Item 3. Incorporation of Documents by Reference.**

The Company hereby incorporates by reference into this Registration Statement the following documents which have been previously filed (not furnished) with the SEC (File No. 001-13463):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The Company's Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC on [<u>April 23, 2025</u>](http://www.sec.gov/ix?doc=/Archives/edgar/data/0001019034/000143774925012824/bkyi20241231_10k.htm) ;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The Company's Quarterly Reports on Form 10-Q for the quarters ended March 31, 2025 filed with the SEC on [<u>May 15, 2025</u>](http://www.sec.gov/ix?doc=/Archives/edgar/data/0001019034/000143774925017209/bkyi20250331_10q.htm) and June 30, 2025 filed with the SEC on [<u>August 13, 2025</u>](http://www.sec.gov/ix?doc=/Archives/edgar/data/0001019034/000143774925026549/bkyi20250630_10q.htm) ;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) The Company's Current Reports on Form 8-K (other than portions thereof furnished under Item 2.02 or Item 7.01 of Form 8-K and exhibits accompanying such reports that are related to such items) filed with the SEC on [<u>January 16, 2025</u>](http://www.sec.gov/ix?doc=/Archives/edgar/data/0001019034/000143774925001242/bkyi20250116_8k.htm) , [<u>April 24, 2025</u>](http://www.sec.gov/ix?doc=/Archives/edgar/data/0001019034/000143774925012986/bkyi20250424_8k.htm) , [<u>May 15, 2025</u>](http://www.sec.gov/ix?doc=/Archives/edgar/data/0001019034/000143774925017237/bkyi20250512_8k.htm) , [<u>August 13, 2025</u>](http://www.sec.gov/ix?doc=/Archives/edgar/data/0001019034/000143774925026550/bkyi20250813_8k.htm) , and [<u>August 20, 2025</u>](http://www.sec.gov/ix?doc=/Archives/edgar/data/0001019034/000143774925027454/bkyi20250820_8k.htm) ; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) The description of the Common Stock contained in Exhibit 4.5 to the Company's Annual Report on Form 10-K for the year ended December 31, 2021 filed with the SEC on [<u>April 1, 2022</u>](http://www.sec.gov/Archives/edgar/data/1019034/000143774922007930/ex_353505.htm) and any amendment or report filed for the purpose of updating such description.

In addition, all other documents filed (not furnished) by the Company pursuant to Section 13(a), Section 13(c), Section 14 or Section 15(d) of the Securities Exchange Act of 1934, as amended, on or after the date of this Registration Statement and prior to the filing of a post-effective amendment to this Registration Statement that indicates that all securities offered hereby have been sold or that deregisters all securities then remaining unsold shall be deemed to be incorporated in this Registration Statement by reference and to be a part of this Registration Statement from the date of filing of such documents; *provided*, *however*, that documents or information deemed to have been furnished to and not filed with the SEC in accordance with the rules of the SEC shall not be deemed incorporated by reference into this Registration Statement.

Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any subsequently filed document which also is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

------

**Item 8. Exhibits.**

The following exhibits are filed with or incorporated by reference into this Registration Statement:

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| 4.1 | [<u>Certificate of Incorporation of BIO-key International, Inc., a Delaware corporation (incorporated by reference to Exhibit 3.1 to the current report on Form 8-K, filed with the SEC on January 5, 2005)</u>](http://www.sec.gov/Archives/edgar/data/1019034/000110465905000401/a05-1096_1ex3d1.htm) |
| 4.2 | [<u>Bylaws (incorporated by reference to Exhibit 3.3 to the current report on Form 8-K, filed with the SEC on January 5, 2005)</u>](http://www.sec.gov/Archives/edgar/data/1019034/000110465905000401/a05-1096_1ex3d3.htm) |
| 4.3 | [<u>Certificate of Amendment to Certificate of Incorporation (incorporated by reference to Appendix A to the definitive proxy statement, filed with the SEC on January 18, 2006)</u>](http://www.sec.gov/Archives/edgar/data/1019034/000110465906002702/a05-22371_1def14a.htm) |
| 4.4 | [<u>Certificate of Amendment of Certificate of Incorporation of Bio-key International, Inc., a Delaware corporation (incorporated by reference to Exhibit 3.4 to the annual report on Form 10-K, filed with the SEC on March 31, 2015)</u>](http://www.sec.gov/Archives/edgar/data/1019034/000143774915006383/ex3-4.htm) |
| 4.5 | [<u>Certificate of Elimination of BIO-key International, Inc. filed October 6, 2015 (incorporated by reference to Exhibit 3.5 to the registration statement on Form S-1 (File No. 333-208747), filed with the SEC on December 23, 2015)</u>](http://www.sec.gov/Archives/edgar/data/1019034/000143774915022736/ex3-5.htm) |
| 4.6 | [<u>Certificate of Designation of Preferences, Rights and Limitations of Series A-1 Convertible Preferred Stock (incorporated by reference to Exhibit 3.1 to the current report on Form 8-K, filed with the SEC on November 2, 2015)</u>](http://www.sec.gov/Archives/edgar/data/1019034/000143774915019339/ex3-1.htm) |
| 4.7 | [<u>Certificate of Designation of Preferences, Rights and Limitations of Series B-1 Convertible Preferred Stock (incorporated by reference to Exhibit 3.1 to the quarterly report on Form 10-Q, filed with the SEC on November 16, 2015)</u>](http://www.sec.gov/Archives/edgar/data/1019034/000143774915020979/ex3-1.htm) |
| 4.8 | [<u>Certificate of Amendment of Certificate of Incorporation of Bio-key International, Inc., a Delaware corporation (incorporated by reference to Exhibit 3.1 to the current report on Form 8-K, filed with the SEC on December 28, 2016)</u>](http://www.sec.gov/Archives/edgar/data/1019034/000143774916043858/ex3-1.htm) |
| 4.9 | [<u>Certificate of Amendment of Certificate of Incorporation of Bio-Key International, Inc., a Delaware corporation (incorporated by reference to Exhibit 3.1 to the current report on Form 8-K, filed with the SEC on November 19, 2020)</u>](http://www.sec.gov/Archives/edgar/data/0001019034/000143774920024192/ex_214807.htm) |
| 4.10 | [<u>Certificate of Amendment to Certificate of Incorporation of BIO-key International, Inc., a Delaware corporation (incorporated by reference to Exhibit 3.1 to the current report on Form 8-K, filed with the SEC on December 19, 2023)</u>](http://www.sec.gov/Archives/edgar/data/1019034/000143774923034827/ex_607847.htm) |
| 4.11 | [<u>Specimen Stock Certificate (incorporated by reference to Exhibit 4.1 to the registration statement on Form SB-2 (File No. 333-16451))</u>](http://www.sec.gov/Archives/edgar/data/1019034/0000897101-97-000009.txt) |
| 5.1 | [Opinion of Fox Rothschild LLP regarding the validity of the shares of Common Stock being registered (Filed herewith)](ex_857573.htm) |
| 23.1 | [Consent of Bush & Associates CPA LLC (Filed herewith)](ex_857574.htm) |
| 23.3 | [Consent of Fox Rothschild LLP (Included within the opinion filed as Exhibit 5.1)](ex_857573.htm) |
| 24.1 | [Power of Attorney (Included on signature page to this Registration Statement)](#poa) |
| 99.1 | [<u>BIO-key International, Inc. 2021 Employee Stock Purchase Plan (incorporated by reference to Appendix A to the definitive proxy statement filed with the SEC on May 4, 2021)</u>](http://www.sec.gov/Archives/edgar/data/1019034/000143774921010774/bkyi20210430_def14a.htm) |
| 99.2 | [<u>Amendment No. 1 to the BIO-key International, Inc. 2021 Employee Stock Purchase Plan (incorporated by reference to Exhibit 10.2 to the current report on Form 8-K, filed with the SEC on August 20, 2025)</u>](http://www.sec.gov/Archives/edgar/data/1019034/000143774921010774/bkyi20210430_def14a.htm) |
| 107 | [Filing Fee Table (Filed herewith)](ex_857575.htm) |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Holmdel, State of New Jersey, on August 28, 2025.

---

| | |
|:---|:---|
| **BIO-KEY INTERNATIONAL, INC.** | **BIO-KEY INTERNATIONAL, INC.** |
| By:  | /s/ Michael W. DePasquale |
| Michael W. DePasquale | Michael W. DePasquale |
| Chief Executive Officer | Chief Executive Officer |

---

**POWER OF ATTORNEY**

We, the undersigned officers and directors of BIO-key International, Inc. hereby severally constitute and appoint Michael W. DePasquale and Cecilia Welch, and each of them singly (with full power to each of them to act alone), our true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution in each of them for each of the undersigned and in each of the undersigned's name, place and stead, and in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement, and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite or necessary to be done in and about the premises, as fully to all intents and purposes as each of the undersigned might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them, or any of their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

---

| | | |
|:---|:---|:---|
| **Name and Signature** | **Title** | **Date** |
| /s/ Michael W. DePasquale | Chairman of the Board of Directors, Chief Executive Officer and Director<br> (Principal Executive Officer) | August 28, 2025 |
| Michael W. DePasquale |  |  |
| /s/ Cecilia Welch | Chief Financial Officer and Secretary<br> (Principal Financial and Accounting Officer) | August 28, 2025 |
| Cecilia Welch |  |  |
| /s/ Robert J. Michel | Director | August 28, 2025 |
| Robert J. Michel |  |  |
| /s/ Wong Kwok Fong | Director | August 28, 2025 |
| Wong Kwok Fong |  |  |
| /s/ Cameron Williams | Director | August 28, 2025 |
| Cameron Williams |  |  |
| /s/ Manny Alia | Director | August 28, 2025 |
| Manny Alia |  |  |

---

## Exhibit 5.1

**Exhibit 5.1**

![frlogo.jpg](frlogo.jpg)

212 Carnegie Center

Suite 400

Princeton, NJ 08540

![i01.jpg](i01.jpg)(609) 896-3600 ![i02.jpg](i02.jpg)(609) 896-1469

www.foxrothschild.com

August 28, 2025

BIO-key International, Inc.

101 Crawfords Corner Road

Suite 4116

Holmdel, NJ 07733

---

| | |
|:---|:---|
| **Re:** | **BIO-key International, Inc.**<br> **Registration Statement on Form S**-**8** |

---

Ladies and Gentlemen:

We have acted as counsel to BIO-key International, Inc., a Delaware corporation (the "Company"), in connection with the Company's registration of an additional 700,000 shares (collectively, the "Shares") of the Company's common stock, par value $0.0001 per share (the "Common Stock"), issuable under the BIO-key International, Inc. 2021 Employee Stock Purchase Plan, as amended (the "Plan"), pursuant to a registration statement on Form S-8 (the "Registration Statement") under the Securities Act of 1933, as amended (the "Securities Act"), filed by the Company with the Securities and Exchange Commission (the "SEC") on August 28, 2025.

In connection with this opinion, we have examined and relied upon the originals, or copies certified or otherwise identified to our satisfaction, of such records, documents, certificates and other instruments as in our judgment are necessary or appropriate to enable us to render the opinions expressed below. As to certain factual matters, we have relied upon certificates of the officers of the Company and have not sought to independently verify such matters.

In rendering this opinion, we have assumed the genuineness and authenticity of all signatures on original documents, including electronic signatures made and/or transmitted using electronic signature technology (e.g., via DocuSign or similar electronic signature technology); that any such signed electronic record shall be valid and as effective to bind the party so signing as a paper copy bearing such party's handwritten signature; the legal capacity of all natural persons; the authenticity of all documents submitted to us as originals; the conformity to originals of all documents submitted to us as certified or photocopies; the authenticity of the originals of such latter documents; the accuracy and completeness of all documents and records reviewed by us; the accuracy, completeness and authenticity of certificates issued by any governmental official, office or agency and the absence of change in the information contained therein from the effective date of any such certificate; and other than for the Company, the due authorization, execution and delivery of all documents where authorization, execution and delivery are prerequisites to the effectiveness of such documents.

Our opinion herein is expressed solely with respect to the General Corporation Law of the State of Delaware (including the statutory provisions, all applicable provisions of the Delaware Constitution and reported judicial decisions interpreting the foregoing) and is based on these laws as in effect on the date hereof. We express no opinion as to whether the laws of any jurisdiction are applicable to the subject matter hereof. We are not rendering any opinion as to compliance with any federal or other state law, rule or regulation relating to securities, or to the sale or issuance thereof.

On the basis of the foregoing and in reliance thereon, and subject to the qualifications herein stated, we are of the opinion that the Shares registered pursuant to the Registration Statement have been duly and validly authorized and reserved for issuance and that upon the issuance of the Shares and payment therefor in accordance with the provisions of the Plan, the Shares will be validly issued, fully paid and non-assessable.

We hereby consent to the filing of this opinion as an exhibit to the Registration Statement. In giving such consent, we do not admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the SEC thereunder. This opinion is expressed as of the date hereof, and we disclaim any undertaking to update or supplement this opinion or to advise you of any subsequent changes in the facts stated or assumed herein or of any subsequent changes in applicable law.

Very truly yours,<br>/s/ Fox Rothschild LLP<br>

## Exhibit 23.1

**Exhibit 23.1**

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

![bacpa.jpg](bacpa.jpg)

To Whom It May Concern:

We hereby consent to the incorporation by reference into the Registration Statement of BIO-key International, Inc. on Form S-8, filed August 28, 2025, of our Report of Independent Registered Public Accounting Firm, dated April 23, 2025 on the balance sheet of BIO-key International Inc. as of December 31, 2024 and 2023 and the related statements of operations, changes in stockholder's equity and cash flows for the years then ended.

Very truly yours,

/s/ Bush & Associates CPA LLC (PCAOB 6797)

Henderson, Nevada

August 28, 2025

179 N. Gibson Rd., Henderson, NV 89014 l 702.703.5979 www.bushandassociatescpas.com

## Ex-Filing

?xml version='1.0' encoding='ASCII'? EX-FILING FEES

---

| |
|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Calculation of Filing Fee Tables**  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **S-8**  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **BIO KEY INTERNATIONAL INC**  |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Security Type**  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Security Class Title**  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Fee Calculation Rule**  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Amount Registered**  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Proposed Maximum Offering Price Per Unit**  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Maximum Aggregate Offering Price**  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Fee Rate**  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Amount of Registration Fee**  |
| 1 | Equity | Common Stock, par value $0.0001 per share | Other | 700000 | $0.758 | $530600.00 | 0.0001531 | $81.23 |
| Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: |  | $530600.00  |  | $81.23  |
| Total Fee Offsets:  | Total Fee Offsets:  | Total Fee Offsets:  | Total Fee Offsets:  | Total Fee Offsets:  |  |  |  | $0.00  |
| Net Fee Due:  | Net Fee Due:  | Net Fee Due:  | Net Fee Due:  | Net Fee Due:  |  |  |  | $81.23  |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Offering Note** <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <sup>1</sup> (1) Pursuant to Rule 416 under the Securities Act of 1933, as amended (the "Securities Act"), this registration statement will also cover any additional shares of common stock, par value $0.0001 per share, of BIO-key International, Inc. (the "Common Stock") that become issuable under the BIO-key International, Inc. 2021 Employee Stock Purchase Plan, as amended, by reason of any stock split, stock dividend, recapitalization or other similar transaction effected without the registrant's receipt of consideration which would increase the number of outstanding shares of Common Stock. (2) Estimated solely for the purpose of calculating the amount of the registration fee and calculated pursuant to Rule 457(c) and Rule 457(h) under the Securities Act on the basis of the average of the high and low sales prices of the Common Stock on August 26, 2025, as reported by the Nasdaq Stock Market. (3) The Registrant does not have any fee offsets.

---

| | |
|:---|:---|
| | |
| **Rule 457(p)** | **Rule 457(p)** |
| Fee Offset Claims | N/A |
| Fee Offset Sources | N/A |

---